Johannesburg Declaration, A civil society declaration to UN Secretary- General High Level Panel on Access to Medicines highlights the factors that interlink system of financing biodmedical research, innovation and access to health technologies. It denounces the research funding that relies upon the grant of monopolies which eventually ‘produces to innovation gaps, inefficiencies, and distortions in the development of new health technologies’. The declaration clearly recommends ‘the costs of medical research and development should be delinked from the price of health technologies.’
- RCEP trade deal negotiators must reject terms that would harm access to medicines
- TPP may be dead – now let’s stop Obama’s other bad trade deals
- After the TPP, what’s next for Australia?
- On World AIDS Day, threat to access to medicines looms large
- Delhi HC sets aside Centre’s decision to ban 344 fixed dose combination drugs